Results 111 to 120 of about 4,199 (162)

An analogue of indapamide: crystal structure and Hirshfeld surface analysis of 3-chloro-4-(<i>N</i>,<i>N</i>-diethynylsulfamo-yl)-<i>N</i>-(2-meth-yl-indolin-1-yl)benzamide. [PDF]

Acta Crystallogr E Crystallogr Commun
Ramli Y, Al Garadi W, Essassi EM, Kalonji Mubengayi C, Alsubari A, Mague JT.   +5 more
europepmc   +1 more source

4-[4-(4-Chloro-1,2,5-thia-diazol-3-yl)phen-yl]morpholine. [PDF]

IUCrdata
Palme PR, Goddard R, Richter A, Imming P, Seidel RW.   +4 more
europepmc   +1 more source

Speech, Language and Non-verbal Communication in CLN2 and CLN3 Batten Disease. [PDF]

J Inherit Metab Dis
Morison LD, Whiteman IT, Vogel AP, Tilbrook L, Fahey MC, Braden R, Bredebusch J, Hildebrand MS, Scheffer IE, Morgan AT.   +9 more
europepmc   +1 more source

Influence of PARP1 on CRISPR/Cas9 induced double strand break repair in proliferating cells. [PDF]

Comput Struct Biotechnol J
Wimmer T, Schneider J, Alabudeeb F, Türk FM, Lytvynchuk L, Stieger K.   +5 more
europepmc   +1 more source

Genetic and Cellular Basis of Impaired Phagocytosis and Photoreceptor Degeneration in CLN3 Disease. [PDF]

Invest Ophthalmol Vis Sci
Han J, Chear S, Talbot J, Swier V, Booth C, Reuben-Thomas C, Dalvi S, Weimer JM, Hewitt AW, Cook AL, Singh R.   +10 more
europepmc   +1 more source

Identifying Drug Repurposing Candidates for CLN3 Targeting Proteomics Expression Profile. [PDF]

Proceedings (IEEE Int Conf Bioinformatics Biomed)
Sun S, Mejia R, Do AND, Zhu Q.
europepmc   +1 more source

Neuronal Ceroid Lipofuscinosis-Concepts, Classification, and Avenues for Therapy. [PDF]

CNS Neurosci Ther
Zhang Y, Du B, Zou M, Peng B, Rao Y.
europepmc   +1 more source

Chromosome duplication causes premature aging via defects in ribosome quality control. [PDF]

PLoS Biol
Escalante LE, Hose J, Ahrens JM, Howe H, Paulsen N, Liss SJ, Place M, Gasch AP.   +7 more
europepmc   +1 more source

Targeted long-read RNA sequencing reveals the complexity of CLN3 transcription and the consequences of the most common 1-kb deletion in patients with juvenile CLN3 disease

Minnis CJ, Zhang H, Gustavsson E, Lee J, Anderson C, Gardner E, Schulz A, Nickel M, Arno G, Jurkute N, Webster AR, Gammaldi N, Santorelli FM, Gissen P, Mills P, Ryten M, Mole SE.   +16 more
europepmc   +1 more source